@glory
i think it'll wake up pretty quick once a bit of news arrives
NTI164 increases Diclofenac efficacy resulting in a Tumor Necrotic Factor - alpha expression reduction of 63% and same same 80% reduction for Interleukin 6 .....these are stunning numbers ....globally.... in the reduction of inflammatory response ...and includes the potential mitigation of Diclofenac side effects ....looking forward to the news
add to that the potential to treat other neuro degenerative conditions such as Alzheimer's and TBI and its looking pretty good right now.
glah
Ann: Preclinical Success with Targeted Combination Therapies, page-20
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
